Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer's Model

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Do Carmo, Sonia ^a   Hanzel, Cecilia E ^a   Jacobs, Marie L ^a   MacHnes, Ziv ^a   Iulita, M Florencia ^a   Yang, Jingyun ^b,c   Yu, Lei ^b,c   Ducatenzeiler, Adriana ^a   Danik, Marc ^a   Breuillaud, Lionel S ^a   Bennett, David A ^b,c   Szyf, Moshe ^a   Cuello, A Claudio ^a  

^a MCGILL UNIVERSITY   (Canada)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84989266773     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34051     Document Type: Article

References (74)

1. Cuello, A. C. Overview of the Alzheimer's disease pathology and potential therapeutic targets. In Pharmacological mechanisms in Alzheimer's therapeutics Cuello, A. C., ed. (Springer, New York), pp. 1-27 (2007).
2. Querfurth, H. W., LaFerla, F. M. Alzheimer's Disease. N Engl J Med 362, 329-344 (2010).
3. LaFerla, F. M., Green, K. N., Oddo, S. Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509 (2007).
4. Han, J. et al. Effect of 5-aza-2-deoxycytidine microinjecting into hippocampus and prelimbic cortex on acquisition and retrieval of cocaine-induced place preference in C57BL/6 mice. Eur J Pharmacol 642, 93-98 (2010).
5. Levenson, J. M. et al. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 281, 15763-15773 (2006).
6. Qureshi, I. A., Mehler, M. F. Epigenetic mechanisms governing the process of neurodegeneration. Mol Aspects Med 34, 875-882 (2013).
7. Bakulski, K. M. et al. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis 29, 571-588 (2012).
8. Chouliaras, L. et al. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol Aging 34, 2091-2099 (2013).
9. Mastroeni, D. et al. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol Aging 31, 2025-2037 (2010).
10. Cadena-del-Castillo, C. et al. Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 41, 845-854 (2014).
11. De Jager, P. L. et al. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 17, 1156-1163 (2014).
12. Iwata, A. et al. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation. Hum Mol Genet 23, 648-656 (2014).
13. Lunnon, K. et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease. Nat Neurosci 17, 1164-1170 (2014).
14. West, R. L., Lee, J. M., Maroun, L. E. Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient. J Mol Neurosci 6, 141-146 (1995).
15. Yu, L. et al. Association of Brain DNA Methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with Pathological Diagnosis of Alzheimer Disease. JAMA Neurol 72, 15-24 (2015).
16. Fuso, A., Seminara, L., Cavallaro, R. A., D'Anselmi, F., Scarpa, S. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci 28, 195-204 (2005).
17. Bottiglieri, T., Reynolds, E. H., Toone, B. K., Carney, M. W. CSF S-adenosylmethionine in neuropsychiatric disorders. Lancet 338, 121 (1991).
18. Morrison, L. D., Smith, D. D., Kish, S. J. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J Neurochem 67, 1328-1331 (1996).
19. Chen, Z. et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10, 433-443 (2001).
20. Fuso, A. et al. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol Cell Neurosci 37, 731-746 (2008).
21. Fuso, A., Nicolia, V., Cavallaro, R.A., Scarpa, S. DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models. J Nutr Biochem 22, 242-251 (2011).
22. Chishty, M., Reichel, A., Abbott, N. J., Begley, D. J. S-adenosylmethionine is substrate for carrier mediated transport at the bloodbrain barrier in vitro. Brain Res 942, 46-50 (2002).
23. Cao, X. J., Huang S. H., Wang, M., Chen, J. T., Ruan, D. Y. S-adenosyl-L-methionine improves impaired hippocampal long-term potentiation and water maze performance induced by developmental lead exposure in rats. Eur J Pharmacol 595, 30-34 (2008).
24. Czyrak, A., Rogoz, Z., Skuza, G., Zajaczkowski, W., Maj, J. Antidepressant activity of S-adenosyl-L-methionine in mice and rats. J Basic Clin Physiol Pharmacol 3, 1-17 (1992).
25. Suchy, J., Lee, S., Ahmed, A., Shea, T. B. Dietary supplementation with S-adenosyl methionine delays the onset of motor neuron pathology in a murine model of amyotrophic lateral sclerosis. Neuromolecular Med 12, 86-97 (2010).
26. Chan, A., Shea, T. B. Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4. Neuromolecular Med 9, 264-269 (2007).
27. Chan, A., Tchantchou, F., Rogers, E. J., Shea, T. B. Dietary deficiency increases presenilin expression, gamma-secretase activity, and Abeta levels: potentiation by ApoE genotype and alleviation by S-adenosyl methionine. J Neurochem 110, 831-836 (2009).
28. Fuso, A. et al. S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol Aging 33, 1482.e1-16 (2012).
29. Lee, S., Lemere, C. A., Frost, J. L., Shea, T. B. Dietary supplementation with S-adenosyl methionine delayed amyloid-and tau pathology in 3xTg-AD mice. J Alzheimers Dis 28, 423-431 (2012).
30. Li, W. et al. Folic acid administration inhibits amyloid-peptide accumulation in APP/PS1 transgenic mice. J Nutr Biochem 26, 883-891 (2015).
31. Ferretti, M. T. et al. Transgenic mice as a model of pre-clinical Alzheimer's disease. Curr Alzheimer Res 8, 4-23 (2011).
32. Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Wilson, R. S. Overview and findings from the Religious Orders Study. Curr Alzheimer Res 9, 628-645 (2012a).
33. Bennett, D. A., Schneider, J. A., Buchman, A. S., Barnes, L. L., Boyle, P. A., Wilson, R. S. Overview and findings from the Rush Memory and Aging Project. Curr Alzheimer Res 9, 646-663 (2012b).
34. Cuello, A. C., Allard, S., Ferretti, M. T. Evidence for the accumulation of Abeta immunoreactive material in the human brain and in transgenic animal models. Life Sci 91, 1141-1147 (2012).
35. Gouras, G. K. et al. Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156, 15-20 (2000).
36. Wirths, O. et al. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett 306, 116-120 (2001).
37. Cong, L., Jia, J., Qin, W., Ren, Y., Sun, Y. Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer's disease. Acta Neurol Belg 114, 195-206 (2014).
38. Sanchez-Mut, J. V. et al. DNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease. Brain 136, 3018-3027 (2013).
39. Fuso, A., Ferraguti, G., Scarpa, S., Ferrer, I., Lucarelli, M. Disclosing bias in bisulfite assay: MethPrimers underestimate high DNA methylation. PLoS One 10, e0118318 (2015).
40. Detich, N., Hamm, S., Just, G., Knox, J. D., Szyf, M. The Methyl Donor S-Adenosylmethionine Inhibits Active Demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-adenosylmethionine. J Biol Chem 278, 20812-20820 (2003).
41. Pakneshan, P., Szyf, M., Farias-Eisner, R., Rabbani, S. A. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J Biol Chem 279, 31735-31744 (2004).
42. Anier, K., Zharkovsky, A., Kalda, A. S-adenosylmethionine modifies cocaine-induced DNA methylation and increases locomotor sensitization in mice. Int J Neuropsychopharmacol 16, 2053-2066 (2013).
43. Cavallaro, R. A., Fuso, A., D'Anselmi, F., Seminara, L., Scarpa, S. The effect of S-adenosylmethionine on CNS gene expression studied by cDNA microarray analysis. J Alzheimers Dis 9, 415-419 (2006).
44. Goren, J. L., Stoll, A. L., Damico, K. E., Sarmiento, I. A., Cohen, B. M. Bioavailability and lack of toxicity of S-adenosyl-Lmethionine (SAMe) in humans. Pharmacotherapy 24, 1501-1507 (2004).
45. Mischoulon, D. et al. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. J Clin Psychiatry 75, 370-376 (2014).
46. Fuso, A. et al. gamma-Secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. J Alzheimers Dis 11, 275-290 (2007).
47. Byun, C. J. et al. DNA methylation of the 5-untranslated region at + 298 and + 351 represses BACE1 expression in mouse BV-2 microglial cells. Biochem Biophys Res. Commun 417, 387-392 (2012).
48. Lange-Dohna, C. et al. Cloning and expression of the rat BACE1 promoter. J Neurosci Res 73, 73-80 (2003).
49. Wilson, E. N. et al. Intraneuronal Amyloid Beta Accumulation Disrupts Hippocampal CRTC1-Dependent Gene Expression and Cognitive Function in a Rat Model of Alzheimer Disease. Cereb Cortex In press (2016).
50. Chan, A., Tchantchou, F., Graves, V., Rozen, R., Shea, T. B. Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: critical role of S-adenosyl methionine. J Nutr Health Aging 12, 252-261 (2008).
51. Cavallaro, R. A., Fuso, A, Nicolia, V & Scarpa, S. S-adenosylmethionine prevents oxidative stress and modulates glutathione metabolism in TgCRND8 mice fed a B-vitamin deficient diet. J Alzheimers Dis 20, 997-1002 (2010).
52. Yamamoto, T., Yatsugi, S., Ohno, M., Ueki, S. Inhibition of mouse-killing behavior by S-adenosyl-L-methionine in midbrain raphelesioned and olfactory-bulbectomized rats. Pharmacol Biochem Behav 34, 395-398 (1989).
53. Bottiglieri, T. et al. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 53, 1096-1098 (1990).
54. Cohen, B. M., Satlin, A., Zubenko, G. S. S-adenosyl-L-methionine in the treatment of Alzheimer's disease. J Clin Psychopharmacol 8, 43-47 (1988).
55. Rudolph, M. L., Rabinoff, M., Kagan, B. L. A Prospective, Open-Label, 12 Week Trial of S-adenosylmethionine in the Symptomatic Treatment of Alzheimer's Disease. Neuroscience and Medicine 2, 222-225 (2011).
56. Remington, R. et al. Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study. J Alzheimers Dis 51, 991-995 (2016).
57. Tannorella, P. et al. Methylation analysis of multiple genes in blood DNA of Alzheimer's disease and healthy individuals. Neurosci Lett 600, 143-147 (2010).
58. Ma, Y. et al. Genetic variants modify the effect of age on APOE methylation in the Genetics of Lipid Lowering Drugs and Diet Network study. Aging Cell 14, 49-59 (2015).
59. Hernandez, F., Gomez de Barreda, E., Fuster-Matanzo, A., Lucas, J. J., Avila, J. GSK3: a possible link between beta amyloid peptide and tau protein. Exp Neurol 223, 322-325 (2010).
60. Sarris, J. et al. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. Am J Psychiatry 173, 575-587 (2016).
61. Guo, T., Chang, L., Xiao, Y., Liu, Q. S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis. PLoS One 10, e0122124 (2015).
62. Grant, S. M., Ducatenzeiler, A., Szyf, M., Cuello, A. C. Abeta immunoreactive material is present in several intracellular compartments in transfected, neuronally differentiated, P19 cells expressing the human amyloid beta-protein precursor. J Alzheimers Dis 2, 207-222 (2000).
63. Iulita, M. F. et al. Intracellular A pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study. Acta Neuropathol Commun 2, 61 (2014).
64. Crudo, A. et al. Prenatal synthetic glucocorticoid treatment changes DNA methylation states in male organ systems: multigenerational effects. Endocrinology 153, 3269-3283 (2012).
65. Pilsner, J. R. et al. Mercury-associated DNA hypomethylation in polar bear brains via the LUminometric Methylation Assay: a sensitive method to study epigenetics in wildlife. Mol Ecol 19, 307-314 (2010).
66. Machnes, Z. M. et al. DNA methylation mediates persistent epileptiform activity in vitro and in vivo. PLoS One 8, e76299 (2013).
67. Wilson, R. S. et al. Conscientiousness, dementia related pathology, and trajectories of cognitive aging. Psychol Aging 30, 74-82 (2015).
68. Schneider, J. A., Arvanitakis, Z., Bang, W., Bennett, D. A. Mixed brain pathologies account for most dementia cases in communitydwelling older persons. Neurology 69, 2197-2204 (2007).
69. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease Report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984).
70. Bennett, D. A., Schneider, J. A., Wilson, R. S., Bienias, J. L., Arnold, S. E. Education modifies the association of amyloid but not tangles with cognitive function. Neurology 65, 953-955 (2005).
71. Boyle, P. A. et al. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol 74, 478-489 (2013).
72. Yang, J. et al. Association of DNA methylation in the brain with age in older persons is confounded by common neuropathologies. Int J Biochem Cell Biol 67, 58-64. (2015).
73. Chibnik, L. B. et al. Alzheimer's loci: epigenetic associations and interaction with genetic factors. Ann Clin Transl Neurol 2, 636-647 (2015).
74. Yu, L. et al. Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology. Alzheimers Dement. pii: S1552-5260(16)00084-4 (2016).